U.S. Healthtech Stock News

Recent performance snapshot for Celanese (CE) Celanese (CE) has caught investor attention after a mixed recent run, with the stock roughly flat over the past 3 months, down about 12% over the past month, and up around 42% year to date. See our latest analysis for Celanese. Despite a recent 12% 1 month share price decline and softer 7 day performance, Celanese still shows stronger momentum over a longer horizon. A 42.24% year to date share price return and a 14.48% 1 year total shareholder...

Fresh Del Monte Produce (NYSE:FDP) plans to participate in the TD Cowen Future of the Consumer Conference. Senior management is scheduled for a fireside chat and one-on-one meetings with investors during the event. The conference appearance offers the company a platform to outline priorities and engage directly with the investment community. For investors tracking NYSE:FDP, this conference comes with the stock recently closing at $35.53 and posting a gain of 14.8% over the past year. Over...

Investors may be wondering whether LCI Industries at around US$110.96 is offering good value right now, or if the easy gains are already behind it. The stock has pulled back recently, with the share price down about 5.1% over the past week and 9.9% over the past month, even though the 1 year return sits at 29.7%. Recent headlines have focused on LCI Industries as investors reassess auto components stocks and their sensitivity to consumer demand and capital spending. This shifting attention...

Earlier in May 2026, Albertsons Companies disclosed that Senior Vice President and Chief Accounting Officer Robert Bruce Larson sold 44,363 Class A shares at around US$16.01–US$16.03 each, leaving him with 53,269 shares, while the retailer also confronted lawsuits, a failed merger and intensifying online grocery competition. These developments, alongside weaker fresh produce sales and a growing dependence on the pharmacy division following an opioid-related settlement, highlight mounting...

Zeta Global Holdings (ZETA) has experienced mixed short-term returns, with a decline over the past week and day, but gains over the past month and past 3 months shaping recent performance. See our latest analysis for Zeta Global Holdings. At a share price of $16.04, Zeta Global Holdings has seen short term share price pressure with its year to date share price return down 19.44%, yet longer term momentum shows through a 95.13% total shareholder return over three years. If Zeta’s recent swings...

What triggered the latest focus on Summit Therapeutics? The recent spotlight on Summit Therapeutics (SMMT) is tied to two developments: a downgrade by H.C. Wainwright following weaker interim HARMONi-3 trial signals, and first quarter results showing a net loss of US$189.42 million. See our latest analysis for Summit Therapeutics. Despite the weaker interim HARMONi-3 update and wider first quarter loss, Summit Therapeutics’ share price has slipped 6.19% over the past month but remains up...

Earlier this month, United States Antimony announced it would release its Q1 2026 results on May 14 and host an earnings call the same day to update investors on its operations. Investor attention has recently centered on a report highlighting United States Antimony’s very large decade-long compounded return, underscoring how long-term holding can materially reshape investment outcomes. We’ll now examine how this renewed focus on United States Antimony’s long-term compounding record may...

Nu Holdings, Latin America's largest digital bank, reported strong full-year results with very large revenue growth and a 33% Q4 return on equity, and also secured conditional approval from the U.S. OCC for a national bank charter. With markets now focused on its Q1 2026 earnings released after the bell on May 14, attention is turning to how Nu’s rapid customer expansion and regional penetration will influence its premium valuation and growth ambitions beyond Latin America. We’ll now examine...

Recent performance triggers fresh interest in eToro Group stock eToro Group (NasdaqGS:ETOR) has drawn fresh attention after a sharp move in its share price, with the stock up 9.8% over the past day and 6.9% over the past week. That short term strength sits alongside a 24.0% gain over the past month and 54.4% over the past 3 months. This has prompted investors to reassess the US$2.99b online trading platform and its current valuation. See our latest analysis for eToro Group. At a share price...

Adecoagro (NYSE:AGRO) reported strong Q1 2026 results with its fertilizer division emerging as the main growth driver. The fertilizers segment, strengthened by the Profertil acquisition, delivered record profitability supported by higher urea prices and improved operational reliability. The company outlined an accelerated deleveraging path and confirmed a focus on sustaining dividends within a new three segment structure. Adecoagro, trading at $13.65, is coming off a strong run, with the...

Why Spire (SR) is back on investors’ radar Spire (SR) has drawn fresh attention after Wells Fargo began coverage alongside increased director share purchases, all coming shortly after the company reported profitable second quarter and six month 2026 results. See our latest analysis for Spire. At a share price of $85.56, Spire has eased in the short term, with the share price return down over the past month and quarter. However, the 1 year and multi year total shareholder returns remain...

In May 2026, QIAGEN N.V. proposed a 40% increase in its annual cash dividend to US$0.35 per share for approval at the June 24, 2026 Annual General Meeting, while also announcing plans to appoint co-founder and former CEO Dr. Metin Colpan as Honorary Chairman after he steps down from the Supervisory Board. The combination of a higher dividend, expanded shareholder return authorizations, and ongoing Supervisory Board renewal underscores how QIAGEN is pairing governance refreshment with a...

HF Sinclair recently reported first-quarter 2026 results, with sales of US$7,123 million and net income of US$648 million, while also completing a US$616.56 million share repurchase program and declaring a regular US$0.50 per-share dividend payable on June 2, 2026. These solid capital returns came as the company confirmed the past departure of CEO Timothy Go and ongoing interim leadership under Chairperson Franklin Myers, keeping corporate governance and succession firmly in focus for...

Why First BanCorp (FBP) is on investors’ radar today First BanCorp (FBP) came into focus after recent trading left the stock modestly lower over the past week, even as its year to date and 1 year total returns remain positive. See our latest analysis for First BanCorp. The recent 1 day share price decline of 1.16% and 7 day share price decline of 4.90% come after a period of steadier gains. A year to date share price return of 10.48% and a 3 year total shareholder return of 123.09% point to...

Why Cardinal Health (CAH) is back in focus after its latest quarter Cardinal Health (CAH) has moved back onto investors’ radar after its third quarter results showed a year-over-year decline in net income and a sizeable goodwill impairment tied to its Navista and ION unit. These profit and impairment headlines came alongside large pharmaceutical distribution sales, ongoing share repurchases, and an updated dividend. Together, they provide several angles to reassess how the stock fits into a...

In early May 2026, Lincoln National reported first‑quarter revenue of US$5,306 million and a net loss of US$172 million, while also announcing expanded managed account offerings with Stadion and Morningstar Retirement and deeper API integration with Centro Benefits Research to streamline broker workflows. Despite the GAAP loss, Lincoln National delivered its seventh consecutive quarter of adjusted operating income growth and continued shifting toward less market‑sensitive products, while...

PepsiCo (NasdaqGS:PEP) is acquiring prebiotic soda brand Poppi in a deal valued at $1.95b. The transaction adds a fast growing functional soda label focused on gut health to PepsiCo’s beverage lineup. The move reflects continued investment in health focused soft drinks alongside the company’s traditional soda and snack offerings. PepsiCo, which last closed at $149.27, has seen the stock rise 4.9% year to date and 20.9% over the past year, while returns over 3 years show a decline of 14.0%...

FMC Corporation recently maintained its 2026 earnings guidance, projecting second-quarter revenue of US$850 million to US$900 million and full-year sales of US$3.60 billion to US$3.80 billion, while confirming a sales decline at the midpoint due to lower prices and the removal of India revenue partly offset by volume growth from new products. Earlier today, FMC’s CEO Pierre Brondeau and CFO Andrew Sandifer spoke at the BMO Global Farm to Market Chemicals Conference in New York, giving...

If you are wondering whether Verisk Analytics at around US$161 a share still represents good value, the current market price alone does not tell the full story. The stock is down 5.5% over the past week, 3.8% over the past month and 26.9% year to date. It has declined 46.0% over the last year and 24.9% over three years, which has shifted how many investors are thinking about both risk and potential upside. Recent headlines have focused on Verisk Analytics as a data and analytics provider in...

Commvault Systems (NasdaqGS:CVLT) is reportedly working with Goldman Sachs to review takeover interest. Potential bidders are said to include both private equity firms and industry buyers. The process is at an exploratory stage and could influence the future ownership and direction of the company. For shareholders, this comes at a time when Commvault Systems is trading at around $99.81, with the stock down 19.6% year to date and down 44.5% over the past year, while still showing a gain of...

Harrow, Inc. reported past first-quarter 2026 results with revenue of US$44.2 million versus US$47.83 million a year earlier and a wider net loss of US$27.6 million, missing analyst expectations on both revenue and earnings. Management attributed much of the revenue pressure to an US$8 million non-recurring VEVYE gross-to-net adjustment while highlighting record VEVYE prescriptions and reaffirming full-year 2026 revenue guidance of US$350 million to US$365 million. We’ll now examine how...

Why Clorox Stock Is on Investors’ Radar Today Clorox (CLX) is drawing fresh attention after recent share price moves. The stock closed at US$92.00 as investors weigh its household, health and wellness, lifestyle, and international product exposure. See our latest analysis for Clorox. The recent 1-day share price return of 3.24% and 7-day share price return of 2.21% come after a tougher patch, with the 30-day share price return down 11.02% and the 90-day share price return down 26.19%. The...

Lexicon Pharmaceuticals, Inc. reported first-quarter 2026 results on May 7, with revenue rising to US$21.1 million from US$1.26 million a year earlier and net loss narrowing to US$1.04 million from US$25.3 million. Alongside this sharp improvement in quarterly financials, Lexicon recently secured up to US$100 million in non-dilutive debt capacity, extending its funding runway for upcoming regulatory and commercial milestones. With revenue sharply higher and net loss greatly reduced, we’ll...

Recent performance and business snapshot AMN Healthcare Services (AMN) has drawn attention after a sharp move in the stock, with recent returns of 4.8% over the past day, roughly 47% over the past week, and about 66% over the past month. Over the past 3 months the stock is up about 90%, while the year to date gain is about 104% and the 1 year total return is about 42%. These moves come as the company reports annual revenue of US$3,419.3m and a net loss of US$32.4m, alongside annual revenue...